|

High Dose Chemotherapy Clinical Trials

1 actively recruiting trial across 1 location

Also known as: high-dose chemotherapy

Pipeline

Phase 3: 1

Top Sponsors

  • Eastern Cooperative Oncology Group1

Indications

  • Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type1
  • Follicular Helper T-Cell Lymphoma1
  • Anaplastic Large Cell Lymphoma, ALK-negative1
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified1
  • Cancer1

Birmingham, Alabama1 trial

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

University of Alabama at Birmingham Cancer Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.